CONCLUSIONS: Within-individual comparisons suggested that risk of suicidal behavior was higher just before and, to a lesser extent, during ADHD medication treatment compared with off-treatment. Further research is needed to determine whether elevations in risk during treatment are attributable to medication effects or to unmeasured time-varying confounding factors, such as a continuation (although attenuated) of the increased risk observed before pharmacotherapy.
